Author

M. J. Turk

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:host-pathogen & immune response· 2 Assay:scRNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:clustering· 1

Frequent Co-Authors

F. W. Kolling· 2 shared P. Rosato· 2 shared A. G. J. Skorput· 1 shared A. Hawkes· 1 shared A. Molodtsov· 1 shared C. Messier· 1 shared C. Park· 1 shared C.-C. Lin· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

F. W. Kolling

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CD39 is expressed on functional effector and tissue resident memory CD8+ T cells

J. F. Isaacs, H. N. Degefu, T. Chen, S. A. Kleist, S. C. Musial, M. A. Ford, T. G. Searles, C.-C. Lin, A. G. J. Skorput, K. Shirai, M. J. Turk, G. J. Zanazzi, P. Rosato

This study identifies CD39 expression on functional effector and tissue-resident memory CD8+ T cells, showing its role in memory differentiation and function, distinct from its role in T cell exhaustion.

bioRxiv · Mar 15, 2024Immunology

Resident memory T cell precursors in tumor draining lymph nodes require type-1 IFN for optimal differentiation

N. Khatwani, T. Searles, J. Han, C. Messier, N. Mittal, A. Molodtsov, D. Ramirez, A. Hawkes, O. M. Williams, Y. H. Huang, F. W. Kolling, P. Rosato, M. J. Turk

bioRxiv · Aug 2, 2023 · PreprintImmunology

CDDO-Methyl Ester Inhibits BRAF Inhibitor Resistance and Remodels the Myeloid Compartment in BRAF-mutant Melanoma

G. M. Torres, H. C. Jarnagin, C. Park, H. Yang, N. N. Kosarek, R. Bhandari, C.-Y. Wang, F. W. Kolling, M. L. Whitfield, M. J. Turk, K. T. Liby, P. A. Pioli

This study shows that CDDO-Methyl Ester reduces BRAF inhibitor resistance in melanoma by altering the tumor microenvironment and myeloid cell composition.

bioRxiv · Aug 1, 2023 · PreprintImmunology